GPR40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
US9988379B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2013 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Nov 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a novel compound having GPR40 receptor agonist activity that promotes insulin secretion and inhibits blood sugar rise after glucose loading, and is thereby useful for the treatment of diabetes and complications thereof, the preparation method thereof and pharmaceutical composition containing them as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.